MELK and small cell lung carcinoma: Our data have also demonstrated that the selective MELK inhibitor OTS167 could attenuate the FOXM1 and Akt pathways leading to caspase-dependent apoptosis of SCLC cells, and possesses strong in vitro growth suppressive effects on CSC-mimic SCLC cell subpopulations.